BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
+8.06%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$267M
AUM Growth
+$267M
(+3.6%)
Cap. Flow
-$4.57M
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
67.14%
Holding
56
New
2
Increased
4
Reduced
30
Closed
8
Top Buys
| 1 |
Visa
V
|
$233K |
| 2 |
American Electric Power
AEP
|
$204K |
| 3 |
Palo Alto Networks
PANW
|
$76.7K |
| 4 |
Eli Lilly
LLY
|
$27.4K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$1.44K |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$864K |
| 2 |
VMW
VMware, Inc
VMW
|
$585K |
| 3 |
UroGen Pharma
URGN
|
$342K |
| 4 |
Intuitive Surgical
ISRG
|
$323K |
| 5 |
Apple
AAPL
|
$294K |
Sector Composition
| 1 | Technology | 35.74% |
| 2 | Consumer Discretionary | 28.37% |
| 3 | Healthcare | 24.05% |
| 4 | Communication Services | 8.46% |
| 5 | Utilities | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Summit Therapeutics
SMMT
$17.7B
| – | – |
-14,059
| Closed | -$17K |
|
|
52
UroGen Pharma
URGN
$904M
| – | – |
-41,131
| Closed | -$342K |
|
|
CMRX
53
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-10,609
| Closed | -$20K |
|
|
BBIG
54
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| – | – |
-80,000
| Closed | -$74K |
|
|
JNCE
55
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-10,000
| Closed | -$23K |
|
|
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-50,000
| Closed | -$60K |
|